CALGB 30601: A phase II study of dasatinib (D) in patients (pts) with previously treated malignant mesothelioma (MM).

Journal Article

Full Text

Duke Authors

Cited Authors

  • Dudek, A; Pang, H; Kratzke, RA; Otterson, GA; Vokes, EE; Kindler, HL

Published Date

  • May 20, 2010

Published In

Volume / Issue

  • 28 / 15_suppl

Start / End Page

  • 7037 - 7037

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2010.28.15_suppl.7037